Novo Nordisk
NVO
NVO
1,508 hedge funds and large institutions have $22.9B invested in Novo Nordisk in 2025 Q1 according to their latest regulatory filings, with 143 funds opening new positions, 617 increasing their positions, 548 reducing their positions, and 246 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,508
Holders Change
-136
Holders Change %
-8.27%
% of All Funds
20.48%
Holding in Top 10
24
Holding in Top 10 Change
-7
Holding in Top 10 Change %
-22.58%
% of All Funds
0.33%
New
143
Increased
617
Reduced
548
Closed
246
Calls
$987M
Puts
$1.34B
Net Calls
-$356M
Net Calls Change
-$427M
Top Buyers
| 1 |
Two Sigma Advisers
New York
|
+$266M |
| 2 |
Capital International Investors
Los Angeles,
California
|
+$191M |
| 3 |
ClearBridge Investments
New York
|
+$163M |
| 4 |
Amundi
Paris,
France
|
+$109M |
| 5 |
Two Sigma Investments
New York
|
+$90.5M |
Top Sellers
| 1 |
GQG Partners
Ft. Lauderdale,
Florida
|
-$894M |
| 2 |
Polen Capital Management
Boca Raton,
Florida
|
-$375M |
| 3 |
Capital World Investors
Los Angeles,
California
|
-$294M |
| 4 |
Renaissance Technologies
New York
|
-$104M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$79.3M |
